---
title: "Enstar Group Pref Share ESGRP 7.0 09/01/28 D | 10-Q: FY2025 Q1 Revenue: USD 204 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238487441.md"
datetime: "2025-05-01T20:09:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238487441.md)
  - [en](https://longbridge.com/en/news/238487441.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238487441.md)
---

# Enstar Group Pref Share ESGRP 7.0 09/01/28 D | 10-Q: FY2025 Q1 Revenue: USD 204 M

Revenue: As of FY2025 Q1, the actual value is USD 204 M.

EPS: As of FY2025 Q1, the actual value is USD 3.32.

EBIT: As of FY2025 Q1, the actual value is USD 55 M.

### Run-off Segment

-   **Revenues**: $14 million for the three months ended March 31, 2025.
-   **Net Incurred Losses and LAE**: - $26 million for the three months ended March 31, 2025.
-   **Defendant Asbestos and Environmental Expenses**: - $1 million for the three months ended March 31, 2025.
-   **Salaries and Benefit Expenses**: $28 million for the three months ended March 31, 2025.
-   **Professional Fee Expenses**: $6 million for the three months ended March 31, 2025.
-   **Other Segment Expenses**: $8 million for the three months ended March 31, 2025.
-   **Segment Net Loss**: - $1 million for the three months ended March 31, 2025.

### Investments Segment

-   **Revenues**: $189 million for the three months ended March 31, 2025.
-   **Income from Equity Method Investments**: $4 million for the three months ended March 31, 2025.
-   **Salaries and Benefit Expenses**: $5 million for the three months ended March 31, 2025.
-   **Professional Fee Expenses**: $1 million for the three months ended March 31, 2025.
-   **Other Segment Expenses**: $4 million for the three months ended March 31, 2025.
-   **Segment Net Income**: $183 million for the three months ended March 31, 2025.

### Corporate and Other

-   **Other Income**: $1 million for the three months ended March 31, 2025.
-   **Net Incurred Losses and LAE**: - $10 million for the three months ended March 31, 2025.
-   **Defendant Asbestos and Environmental Expenses**: - $5 million for the three months ended March 31, 2025.
-   **Amortization of Net Deferred Charge Assets**: - $30 million for the three months ended March 31, 2025.
-   **General and Administrative Expenses**: - $40 million for the three months ended March 31, 2025.
-   **Interest Expense**: - $23 million for the three months ended March 31, 2025.
-   **Net Foreign Exchange Losses**: - $16 million for the three months ended March 31, 2025.
-   **Dividends on Preferred Shares**: - $9 million for the three months ended March 31, 2025.
-   **Total Net Loss**: - $132 million for the three months ended March 31, 2025.

### Outlook

The company anticipates receiving all requisite regulatory approvals for the merger by mid-2025, with the merger expected to close in mid-2025.

### Related Stocks

- [ESGRP.US](https://longbridge.com/en/quote/ESGRP.US.md)
- [ESGRF.US](https://longbridge.com/en/quote/ESGRF.US.md)